Evidence map›Paper›PMID 25710004›Full record

ArticleBioMed research international2015

Impairment of neutrophil migration to remote inflammatory site during lung histoplasmosis.

Alexandra I Medeiros, Adriana Secatto, Caroline Bélanger, Carlos A Sorgi, Pierre Borgeat, Sylvie Marleau, Lúcia H Faccioli

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Alexandra I MedeirosSchool of Pharmaceutical Sciences, UNESP, 14801-902 Araraquara, SP, Brazil.
Adriana SecattoFaculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, 14040-903 Ribeirão Preto, SP, Brazil.
Caroline BélangerFaculty of Pharmacy, Université de Montréal, Montréal, QC, Canada H3T 1J4.
Carlos A SorgiFaculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, 14040-903 Ribeirão Preto, SP, Brazil.
Pierre BorgeatCentre de Recherche en Rhumatologie et Immunologie, Centre de Recherche du CHUQ (CHUL), Sainte-Foy, QC, Canada G1V 4G2.
Sylvie MarleauFaculty of Pharmacy, Université de Montréal, Montréal, QC, Canada H3T 1J4.ORCID 0000-0002-9392-1989
Lúcia H FaccioliFaculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, 14040-903 Ribeirão Preto, SP, Brazil.
Universidade de São Paulo · BRUniversité de Montréal · CACentro Universitário de Araraquara · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Histoplasma capsulatum (Hc) induces a pulmonary disease in which leukotrienes promote activation and recruitment of effectors cells. It is also well-recognized that leukotriene B4 (LTB4) and platelet-activating factor (PAF) induce leukocyte recruitment to inflammatory sites. We investigated the impact of pulmonary Hc infection on PMN migration to a remote inflammatory site. Our results show that pulmonary Hc infection impairs LTB4- or PAF-stimulated PMN recruitment to air pouch. Yet, remote inflammation did not modify PMN numbers in the bronchoalveolar lavage fluid (BALF) of Hc-infected mice. Interestingly, the concomitant administration of PAF and LTB4 receptor antagonists inhibited PMN recruitment to both BALF and the remote site, demonstrating cooperation between both mediators. Along that line, our results show that PAF-elicited PMN chemotaxis was abrogated in 5-lipoxygenase-deficient animals. These results suggest caution in the indiscriminate use of anti-inflammatory drugs during infectious diseases.

Indexed as

AnimalsAnti-Inflammatory AgentsCell MovementHistoplasmosisInflammationLungLung Diseases, FungalMaleMiceMice, Inbred C57BLNeutrophil ActivationNeutrophilsTreatment OutcomeAnti-Inflammatory Agents

Identifiers

PMID25710004
PMCPMC4325970
OpenAlexW2030690931

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.